Renal osteodystrophy, phosphate homeostasis, and vascular calcification

Related Experiment Video

Updated: Jul 13, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

Keith A Hruska1, Georges Saab, Suresh Mathew

  • 1Renal Division, Departments of Pediatrics and Medicine, Washington University, St. Louis, Missouri 63110, USA. hruska_k@kids.wustl.edu

Seminars in Dialysis
|July 20, 2007
PubMed

Insights

Renal osteodystrophy (ROD) is now understood to impact survival beyond bone health in chronic kidney disease (CKD). New insights reveal ROD affects bone formation and is linked to cardiovascular risk, offering new treatment avenues.

Area of Science:

  • Nephrology
  • Endocrinology
  • Bone Biology

Background:

  • Renal osteodystrophy (ROD) is a complication of chronic kidney disease (CKD).
  • Traditionally viewed as a skeletal disorder, its broader impact on CKD survival is increasingly recognized.
  • Key factors like calcium, phosphate, parathyroid hormone (PTH), and vitamin D play critical roles in CKD outcomes.

Purpose of the Study:

  • To review recent discoveries in ROD pathogenesis.
  • To re-evaluate the role of ROD in CKD survival and mortality.
  • To highlight ROD as a treatable component of CKD.

Main Methods:

  • Literature review of recent advances in renal osteodystrophy research.
  • Analysis of the relationship between ROD, bone metabolism, and CKD progression.
  • Examination of the impact of ROD on survival and cardiovascular risk in CKD patients.

Main Results:

  • Renal injury impairs skeletal anabolism, reducing osteoblast numbers and bone formation.
  • Parathyroid hormone (PTH) regulation of the hematopoietic stem cell niche redefines secondary hyperparathyroidism in CKD.
  • ROD is an underappreciated contributor to hyperphosphatemia and cardiovascular risk in CKD.

Conclusions:

  • ROD is more than a skeletal disorder; it's a significant factor in CKD mortality.
  • Understanding ROD's complex role offers new therapeutic targets.
  • Treating ROD can improve survival and reduce cardiovascular risk in CKD patients.

More Related Videos

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
What is the Skeletal System?01:02

What is the Skeletal System?

Overview